Assurex Health, a personalized medicine company dedicated to helping clinicians find the right drug and dose for individual patients, was named a 2013 Venture of the Year Finalist by the Ohio Venture Association.
Ohio-based companies that received one round of professional capital, or exited in the last 12 months, were eligible for nomination. The voting committee then considered factors including growth, milestones met, partnerships, job creation, progress and national recognition.
Current OVA president Jim Weisman said, “In Assurex, we saw a company that wasn’t just poised for healthy growth, but also a company that has a great impact on the biosciences and on the lives of people.”
“We are thrilled with the Ohio Venture Association honor,” said Assurex President and CEO James Burns. “The selection of Assurex as an OVA finalist is a testament to all of our Assurex colleagues who are making state-of-the-art personalized medicine products available to help clinicians individualize the selection of medications for patients with neuropsychiatric and other disorders.”